Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humanchemie is a specialized German medical technology company that develops and manufactures advanced dental materials for endodontics and periodontology. Established in 1974, the company is best known for its proprietary "System Depotphorese" (Depotphoresis), a biochemical method designed for the comprehensive disinfection of the root canal system. Their flagship product, Cupral (copper-calcium hydroxide), is highly regarded in the dental community for its potent bactericidal properties and its ability to promote the regeneration of periapical tissue. Humanchemie focuses on tooth preservation through innovative mineral-based chemical treatments rather than traditional mechanical procedures alone. The company maintains its headquarters and manufacturing facilities in Alfeld, Germany, serving dental professionals globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humanchemie.